Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yvonne, Arvidsson"'
Autor:
Bilal Almobarak, Vishal Amlani, Linda Inge, Tobias Hofving, Andreas Muth, Ola Nilsson, Martin Johansson, Yvonne Arvidsson, Erik Elias
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Small intestinal neuroendocrine tumors (SI-NET) are highly differentiated and genetically stable malignant tumors, yet they often present with advanced metastatic spread at the time of diagnosis. In contrast to many other types of
Externí odkaz:
https://doaj.org/article/d055bd62c17549389cf2301a57fd0067
Autor:
Oi Kuan Choong, Rasmus Jakobsson, Anna Grenabo Bergdahl, Sofia Brunet, Ambjörn Kärmander, Jesper Waldenström, Yvonne Arvidsson, Gülay Altiparmak, Jonas A Nilsson, Joakim Karlsson, Kristina Nyström, Martin E Johansson
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279578 (2023)
The SARS-CoV-2 virus is currently causing a global pandemic. Infection may result in a systemic disease called COVID-19, affecting primarily the respiratory tract. Often the gastrointestinal tract and kidneys also become involved. Angiotensin convert
Externí odkaz:
https://doaj.org/article/f28a977813c747dbadd8cdc0647b2fa2
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine
Autor:
Erik Elias, Arman Ardalan, Markus Lindberg, Susanne E. Reinsbach, Andreas Muth, Ola Nilsson, Yvonne Arvidsson, Erik Larsson
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-8 (2021)
Small intestine neuroendocrine tumors (SI-NETs) are frequently multifocal and metastatic, but their tumourigenesis is still poorly understood. Here, the authors analyse multifocal SI-NET tumours with whole-genome sequencing, revealing the landscape o
Externí odkaz:
https://doaj.org/article/123fb58011ff4c5299d20a2fa8383e2b
Autor:
Tobias Hofving, Erik Elias, Anna Rehammar, Linda Inge, Gülay Altiparmak, Marta Persson, Erik Kristiansson, Martin E. Johansson, Ola Nilsson, Yvonne Arvidsson
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Patients with small intestinal neuroendocrine tumors (SINETs) frequently present with lymph node and liver metastases at the time of diagnosis, but the molecular changes that lead to the progression of these tumors are largely unk
Externí odkaz:
https://doaj.org/article/110de40eae1b4d18802b69af24c99a76
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine
Autor:
Erik Larsson, Susanne Reinsbach, Erik Elias, Ola Nilsson, Andreas Muth, Arman Ardalan, Yvonne Arvidsson, Markus Lindberg
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-8 (2021)
Nature Communications
Nature Communications
Small intestine neuroendocrine tumor (SI-NET), the most common cancer of the small bowel, often displays a curious multifocal phenotype with several tumors clustered together in a limited intestinal segment. SI-NET also shows an unusual absence of dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14953aeba2b0ff654cef610a5aedf31a
https://doi.org/10.1101/2020.05.06.080499
https://doi.org/10.1101/2020.05.06.080499
Autor:
Christina Swärd, Anna Rehammar, Ola Nilsson, Yvonne Arvidsson, Bo Wängberg, Gülay Altiparmak, Ellinor Andersson, Erik Kristiansson, Anders Bergström
Publikováno v:
Modern Pathology. 31:1302-1317
The aim of this study was to define the miRNA profile of small intestinal neuroendocrine tumors and to search for novel molecular subgroups and prognostic biomarkers. miRNA profiling was conducted on 42 tumors from 37 patients who underwent surgery f
Autor:
Tobias Hofving, Yvonne Arvidsson, Ellinor Andersson, Christina Swärd, Erik Kristiansson, Bo Wängberg, Ola Nilsson
Publikováno v:
Modern Pathology. 29:616-629
We wanted to define the transcriptome of small intestinal neuroendocrine tumors in order to identify clinically relevant subgroups of tumors, prognostic markers and novel targets for treatment. Genome-wide expression profiling was conducted on tumor
Autor:
Tobias, Hofving, Yvonne, Arvidsson, Bilal, Almobarak, Linda, Inge, Roswitha, Pfragner, Marta, Persson, Göran, Stenman, Erik, Kristiansson, Viktor, Johanson, Ola, Nilsson
Publikováno v:
Endocrine-Related Cancer
Experimental models of neuroendocrine tumour disease are scarce, and no comprehensive characterisation of existing gastroenteropancreatic neuroendocrine tumour (GEPNET) cell lines has been reported. In this study, we aimed to define the molecular cha
Autor:
Johanna, Dalmo, Johan, Spetz, Mikael, Montelius, Britta, Langen, Yvonne, Arvidsson, Henrik, Johansson, Toshima Z, Parris, Khalil, Helou, Bo, Wängberg, Ola, Nilsson, Maria, Ljungberg, Eva, Forssell-Aronsson
Publikováno v:
EJNMMI Research
Background 177Lu-[DOTA0, Tyr3]-octreotate (177Lu-octreotate) is used for treatment of patients with somatostatin receptor (SSTR) expressing neuroendocrine tumors. However, complete tumor remission is rarely seen, and optimization of treatment protoco
Autor:
Tobias Hofving, Yvonne Arvidsson, Anna-Karin Elf, Peter Bernhardt, Eva Forssell-Aronsson, Ola Nilsson, Viktor Johanson, Bo Wängberg
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 58(2)
Neuroendocrine tumors (NETs) can be treated by peptide receptor radionuclide therapy using radiolabeled somatostatin analogs. However, the efficacy of such treatment is low and needs to be optimized. Our study evaluated the potential radiosensitizing